Cipla launches antiviral nasal spray
When it comes to protecting against the SARS-CoV-2 virus that causes COVID, Cipla Healthcare's Naselin Antiviral Nasal Spray with Povidone Iodine may be an effective first line of protection.
Research on povidone iodine indicated that it gives protection against coronavirus and respiratory tract infections, according to Cipla's health sector. The spray was produced as a result. Because of its antiviral qualities, it can be used to treat and protect critical service employees.
When applied in spray form, the Povidone iodine molecule provides antiviral, antibacterial and antifungal protection against viruses and other organisms that cause colds, sinusitis or the flu, which are typical upper respiratory tract disorders.
It has been used in items like mouthwash, ointments, and lotions for years. However, it's never been connected to a nasal spray before." A recent study by Cipla Health suggests and advises this innovation may call for early isolation in an infection.
"Studies have revealed that the nose is a major entry point for the SARS-CoV-2 virus, and the spray may be able to eliminate disease-causing viruses and germs in the nose." As a result, topical antiviral medications can be used efficiently in the nasal region while using the spray as a prophylactic measure. As patients return to normalcy, it can be taken as a daily preventive help for nose care.
"This is one of the most unique and effective product formulations for coronavirus preventative care," ShivamPuri, CEO of Cipla Health Ltd, stated in response to the announcement of the nasal spray that can guard against COVID. Using Naselin, a spray nasal antiviral, together with other measures like wearing masks, cleaning hands, and avoiding close contact can help us all combat this pandemic."
The Rs 99 15ml spray bottle is available in 700 Apollo and Medplus pharmacies in Maharashtra, Andhra Pradesh and Telangana, as well as on online e-commerce platforms.